Navigation Links
Nektar Announces that FDA Grants Fast Track Designation to NKTR-181, a New Oral Opioid Analgesic Molecule, for the Treatment of Moderate to Severe Chronic Pain
Date:6/7/2012

SAN FRANCISCO, June 7, 2012 /PRNewswire/ -- Nektar Therapeutics (NASDAQ: NKTR) announced today that the U.S. Food and Drug Administration (FDA) has designated NKTR-181 as a Fast Track development program for the treatment of moderate to severe chronic pain.  NKTR-181 is a novel mu-opioid agonist molecule, which is designed to have a slow rate of entry into the brain to reduce the attractiveness of the molecule as a target of abuse and to reduce its CNS-mediated side effects. NKTR-181 was created using Nektar's proprietary polymer conjugate technology and its potential differentiating properties are inherent to the design of the new molecule.  NKTR-181 is an NCE and as a new molecular structure does not rely on a formulation approach to prevent its conversion into an abusable form of an opioid.

"We are very pleased that the NKTR-181 development program has been granted Fast Track designation and we look forward to working closely with the FDA on this program," said Robert Medve, MD, Chief Medical Officer of Nektar Therapeutics.  "NKTR-181 could have significant advantages over currently-available opioids, including reduced attractiveness for abuse and reduced CNS-mediated side effects, such as sedation and respiratory depression.  As a new chemical entity with these properties, we believe NKTR-181 has the potential to transform the treatment of chronic pain.  We are excited about advancing NKTR-181 into Phase 2 development in July of this year." 

Nektar requested Fast Track designation from the FDA for NKTR-181 based upon what is known about its safety and efficacy profile to-date from both preclinical and Phase 1 clinical studies, as well as NKTR-181's potential to treat chronic pain conditions with an improved safety profile over existing therapies. Given the properties and potential of NKTR-181 in the treatment of chronic pain, Nek
'/>"/>

SOURCE Nektar Therapeutics
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6

Related medicine technology :

1. Nektar Therapeutics President and CEO Howard W. Robin to Present at the Jefferies 2012 Global Healthcare Conference in New York
2. Nektar Therapeutics Reports Financial Results for the First Quarter of 2012
3. Nektar to Announce Financial Results for the First Quarter of 2012 on Wednesday, May 2, 2012, After Close of U.S.-Based Financial Markets
4. Brain Research Foundation Announces Grant To Study Concussive Events Among Grade School Children
5. ERT Announces Clearance from German Federal Cartel Office
6. Vanda Pharmaceuticals Announces Date of Annual Meeting of Stockholders
7. American Oriental Bioengineering Inc. Announces Suspension of Trading in its Common Stock and the Initiation of Delisting Proceedings by NYSE
8. SIRO Clinpharm Announces a Fabulous Date With the Dueling Pianos
9. Tris Pharma Announces Approval of First-Ever Generic to Delsym® Dextromethorphan Polistirex Extended-Release Suspension
10. Taiho Pharmaceutical Announces Start of Global Phase III Clinical Trial in Metastatic Colorectal Cancer with Novel Antitumor Agent TAS-102
11. The Galien Foundation Announces New "Best Medical Technology" Award Category for 2012 Prix Galien USA Awards Program
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/27/2015)... 27, 2015 The Elekta Linac-based ... Boston on July 9th for its ... to more fully exploit the potential of advances in ... diseases. "As an established provider of sophisticated ... assume a leadership role - in collaboration with its ...
(Date:8/27/2015)... SAN FRANCISCO, Calif. , Aug. 27, 2015 ... and Veracyte, Inc. (NASDAQ: VCYT ... a U.S. patient survey to advance understanding of ... including idiopathic pulmonary fibrosis (IPF). The Interstitial Lung ... steps and time required for patients to receive ...
(Date:8/27/2015)... MENLO PARK, Calif. , Aug. 27, 2015 ... and the "Company"), a biopharmaceutical company focused on the ... that it will release its year-end financial results for ... September 4, 2015. DelMar,s management team ... webcast for investors, analysts and other interested parties on ...
Breaking Medicine Technology:New Elekta Consortium to Push Frontiers of Linear Accelerator-Based Stereotactic Radiation Therapy for the Brain 2New Elekta Consortium to Push Frontiers of Linear Accelerator-Based Stereotactic Radiation Therapy for the Brain 3Pulmonary Fibrosis Foundation and Veracyte Partner on Survey Exploring Diagnostic Experiences of U.S. Patients with Interstitial Lung Disease 2Pulmonary Fibrosis Foundation and Veracyte Partner on Survey Exploring Diagnostic Experiences of U.S. Patients with Interstitial Lung Disease 3Pulmonary Fibrosis Foundation and Veracyte Partner on Survey Exploring Diagnostic Experiences of U.S. Patients with Interstitial Lung Disease 4DelMar Pharmaceuticals to Announce Fiscal 2015 Year-End Financial Results on September 4, 2015 2DelMar Pharmaceuticals to Announce Fiscal 2015 Year-End Financial Results on September 4, 2015 3
... , HAMBURG , Feb. 3 ... Therapy (NPWT) will assemble this week to develop a comprehensive, ... Expert Panel is drafting recommendations for a range of NPWT ... clinical evidence.  Where published evidence is insufficient, the Panel will ...
... , , ... Technologies ® announced today the hiring of Ron Peele ... to a commercial business.  Mr. Peele has spent the past 25 ... joins STB® from Revolution Health, where he was a founding investor ...
Cached Medicine Technology:International NPWT Expert Panel Convenes in Hamburg 2International NPWT Expert Panel Convenes in Hamburg 3Ron Peele Named President of STB Lifesaving Technologies(R) 2Ron Peele Named President of STB Lifesaving Technologies(R) 3
(Date:8/27/2015)... ... August 27, 2015 , ... NetDimensions is once again named among ... platforms required not only to effectively deliver, curate and administer great programs, but also ... , For six consecutive years, NetDimensions has maintained its position on this Top ...
(Date:8/27/2015)... ... ... "I need a little help supporting and stabilizing myself when getting into ... "I developed this support handle to give me the extra little boost that I ... a helping hand when stepping into or out of the tub or shower. The ...
(Date:8/27/2015)... ... 27, 2015 , ... Standifer Insurance Group, a full service ... a joint charity drive with the Meadow View Elementary School in Alabaster. , ... and many lack the simple supplies necessary for a productive scholastic career. In ...
(Date:8/27/2015)... PA (PRWEB) , ... August 27, 2015 , ... An ... good sleep. "My knees tend to knock against each other while I’m trying to ... to prevent this from happening." , The easy-to-use, ergonomic BTKG BED TIME KNEE GUARD ...
(Date:8/27/2015)... ... August 27, 2015 , ... ... the optical industry announces its new SightLine Proximity Computer Reading Glasses. ... reading glasses. SightLine lenses are engineered with variable magnification levels so whether ...
Breaking Medicine News(10 mins):Health News:NetDimensions Named Among Top 20 Learning Portal Companies of 2015 2Health News:NetDimensions Named Among Top 20 Learning Portal Companies of 2015 3Health News:Inventor and InventHelp Client Develops Bathroom Stabilization Aid (LCC-432) 2Health News:Standifer Insurance Group Initiates Charity Drive to Provide School Supplies for Underprivileged Meadow View Elementary Students 2Health News:Standifer Insurance Group Initiates Charity Drive to Provide School Supplies for Underprivileged Meadow View Elementary Students 3Health News:Finally a better pair of reading glasses for Computer users; Introducing SightLine Computer Reading Glasses with patented multifocal lens technology 2
... Year-Round Immune Support is Best to Ensure the Body,s Peak ... Performance When You Need it ... against infection requires a strong and healthy immune system.,Keeping the immune ... cold season., "It is believed that our immune system is ...
... (February 25, 2008) HealthGrades, the nations ... Americas 50 Best Hospitals, an elite class ... Best Hospital designation represents the healthcare industrys ... clinical outcomes among U.S. hospitals. ...
... module, targeting ... ... and Management Systems Society (HIMSS) 2008 Annual,Conference & Exhibition, Microsoft Corp. ... solution designed to,help healthcare organizations identify potential adverse events that occur,during ...
... cell differentiation into different kinds of tissues in embryos, plays ... life, said researchers from Baylor College of Medicine in Houston ... Nature Medicine. Their findings may provide a basis for understanding ... bone. , We knew that Notch is important in patterning ...
... are Treating the Disease as Chronic, ... Relapsing Brain Disorder, Advances Made in Understanding Biology of ... ,Moral Failing, to ,Legitimate ... Expert, NEW YORK, Feb. 24 Although the American Medical,Association recognized addiction ...
... the Lesbian, Gay, Bisexual and Transgender ... Movement By Early Microsoft Employee Pride Foundation ... Pride Foundation of Seattle is honored,to announce the establishment of ... Weiland,s gift of $65 million is the largest single bequest,ever ...
Cached Medicine News:Health News:Prime Your Immune System During the Peak of Cold Season and Beyond 2Health News:America's 50 best hospitals 2008 released by HealthGrades 2Health News:America's 50 best hospitals 2008 released by HealthGrades 3Health News:Microsoft Introduces Patient Safety Screening Tool to Stop Spread of In-Hospital Infections 2Health News:Microsoft Introduces Patient Safety Screening Tool to Stop Spread of In-Hospital Infections 3Health News:Microsoft Introduces Patient Safety Screening Tool to Stop Spread of In-Hospital Infections 4Health News:Notch controls bone formation and strength 2Health News:NEWSWEEK Cover: The Hunt for an Addiction Vaccine 2Health News:NEWSWEEK Cover: The Hunt for an Addiction Vaccine 3Health News:NEWSWEEK Cover: The Hunt for an Addiction Vaccine 4Health News:Ric Weiland Leaves $65 Million to Support Gay Rights and HIV/AIDS Organizations 2Health News:Ric Weiland Leaves $65 Million to Support Gay Rights and HIV/AIDS Organizations 3
... Laboratories is a national reference laboratory and ... and development. ARUP offers an extensive test ... tests in clinical and anatomic pathology. Owned ... clients include more than half of the ...
... ARUP Laboratories is a national reference laboratory ... research and development. ARUP offers an extensive ... medical tests in clinical and anatomic pathology. ... Laboratories' clients include more than half of ...
... reference laboratory and a worldwide leader in ... an extensive test menu of highly complex ... anatomic pathology. Owned by the University of ... half of the nation's university teaching hospitals ...
... Laboratories is a national reference laboratory and ... and development. ARUP offers an extensive test ... tests in clinical and anatomic pathology. Owned ... clients include more than half of the ...
Medicine Products: